EDSA Earnings

Quarterly EPS
$-0.30
Q4 2024
$-0.48
Q1 2025
$-0.30
Q2 2025
$-0.25
Q3 2025
$-0.32
Q4 2025
$-0.28
Q1 2026
$-0.49
Q2 2026
$-0.60
Q3 2026
Latest RevenueN/A
Latest Net Income-5407611
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.600-5407611-140.0%
Q2 2026-$0.490-4218332-63.3%
Q1 2026-$0.280-2247669+41.7%
Q4 2025-$0.320-2228358-6.7%
Q3 2025-$0.250-1749464+51.9%
Q2 2025-$0.300-1590448+48.3%
Q1 2025-$0.480-1617253+11.1%
Q4 2024-$0.300-962051+47.4%
Q3 2024-$0.520-1668212
Q2 2024-$0.580-1861331
Q1 2024-$0.540-1678451
Q4 2023-$0.570-1720343
Edesa Biotech, Inc. Common Shares (EDSA) — Earnings